|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM180888765 |
003 |
DE-627 |
005 |
20250209150028.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2008 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2008.05.008
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0603.xml
|
035 |
|
|
|a (DE-627)NLM180888765
|
035 |
|
|
|a (NLM)18625437
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Yu, Grace
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Focus on FOCIS
|b the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease
|
264 |
|
1 |
|c 2008
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 03.09.2008
|
500 |
|
|
|a Date Revised 09.03.2022
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Chronic granulomatous disease (CGD) is a primary immunodeficiency of defective neutrophil oxidative burst activity due to mutations in the genes CYBA, NCF-1, NCF-2, and CYBB, which respectively encode the p22-phox, p47-phox, p67-phox, and gp91-phox subunits. CGD usually presents in early childhood with recurrent or severe infection with catalase-positive bacteria and fungi. We present an unusual case of CGD in which Burkholderia cepacia lymphadenitis developed in a previously healthy 10-year-old girl. Flow cytometric analysis of dihydrorhodamine (DHR)-labeled neutrophils performed by a CLIA-approved outside reference laboratory was reported as normal. However, we found that this patient's neutrophil oxidative burst activity in DHR assays was substantially reduced but not absent. A selective decrease in intracellular staining for p67-phox suggested the diagnosis of autosomal recessive CGD due to NCF-2 gene mutations, and a novel homozygous and hypomorphic NCF-2 gene mutation was found. The potential mechanisms for this delayed and mild presentation of CGD are discussed
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Phosphoproteins
|2 NLM
|
650 |
|
7 |
|a neutrophil cytosol factor 67K
|2 NLM
|
650 |
|
7 |
|a NADPH Oxidases
|2 NLM
|
650 |
|
7 |
|a EC 1.6.3.-
|2 NLM
|
650 |
|
7 |
|a NCF2 protein, human
|2 NLM
|
650 |
|
7 |
|a EC 1.6.3.1
|2 NLM
|
700 |
1 |
|
|a Hong, David K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dionis, Kira Y
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rae, Julie
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Heyworth, Paul G
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Curnutte, John T
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lewis, David B
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 128(2008), 2 vom: 31. Aug., Seite 117-26
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnas
|
773 |
1 |
8 |
|g volume:128
|g year:2008
|g number:2
|g day:31
|g month:08
|g pages:117-26
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2008.05.008
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 128
|j 2008
|e 2
|b 31
|c 08
|h 117-26
|